Specific and potent interactions of carbamazepine with brain adenosine receptors.
暂无分享,去创建一个
R. Post | J. Patel | S. Weiss | P. Marangos | K. Zander | A. Parma | Karl J. Zander
[1] D. Rubinow,et al. Biochemical effects of carbamazepine: Relationship to its mechanisms of action in affective illness , 1983, Progress in Neuro-psychopharmacology and Biological Psychiatry.
[2] R. Post,et al. Kindling and Carbamazepine in Affective Illness , 1982, The Journal of nervous and mental disease.
[3] W. Catterall,et al. Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. , 1982, Molecular pharmacology.
[4] J. Patel,et al. Specific calcium antagonist binding sites in brain. , 1982, Life sciences.
[5] L. P. Davies,et al. A purinergic component in the anticonvulsant action of carbamazepine? , 1982, European journal of pharmacology.
[6] J. Boulenger,et al. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. , 1982, Molecular pharmacology.
[7] J. Patel,et al. [3H]Nitrobenzylthioinosine Binding as a Probe for the Study of Adenosine Uptake Sites in Brain , 1982, Journal of neurochemistry.
[8] R. Post,et al. Carbamazepine, Temporal Lobe Epilepsy, and Manic-Depressive Illness , 1982 .
[9] F. Goodwin,et al. Characterization of adenosine receptors in brain using N6 cyclohexyl [3H]adenosine , 1982, Brain Research.
[10] J. Patel,et al. Properties of [3H] beta-carboline-3-carboxylate ethyl ester binding to the benzodiazepine receptor. , 1981, Life sciences.
[11] P. Marangos,et al. Studies on the relationship of gamma-aminobutyric acid-stimulated diazepam binding and the gamma-aminobutyric acid receptor. , 1981, Molecular pharmacology.
[12] S. Snyder,et al. Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Post,et al. Carbamazepine in manic-depressive illness: a new treatment. , 1980, The American journal of psychiatry.
[14] F. Goodwin,et al. Demonstration of specific high affinity binding sites for [3H] imipramine in human brain. , 1980, Life sciences.
[15] J. Leysen,et al. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.
[16] R. Julien,et al. Effect of Carbamazepine on the In Vitro Uptake and Release of Norepinephrine in Adrenergic Nerves of Rabbit Aorta and in Whole Brain Synaptosomes , 1977, Epilepsia.
[17] E. Lewin,et al. Cyclic AMP Accumulation in Cerebral Cortical Slices: Effect of Carbamazepine, Phenobarbital, and Phenytoin , 1977, Epilepsia.
[18] S. Snyder,et al. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. , 1977, Molecular pharmacology.
[19] S. Snyder,et al. Beta adrenergic receptor binding in membrane preparations from mammalian brain. , 1976, Molecular pharmacology.
[20] J. Wada,et al. Prophylactic effects of phenytoin, phenobarbital, and carbamazepine examined in kindling cat preparations. , 1976, Archives of neurology.
[21] B. G. White,et al. Carbamazepine for epilepsy , 1974, Neurology.
[22] S. Snyder,et al. Muscarinic cholinergic binding in rat brain. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[23] S. Garattini,et al. Carbamazepine plasma and tissue levels in the rat. , 1971, Biochemical pharmacology.
[24] R. Post,et al. The efficacy of carbamazepine in affective illness. , 1984, Advances in biochemical psychopharmacology.
[25] Maynert Ew,et al. The role of the neurotransmitters in the epilepsies. , 1975 .